[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"currency-rates":3,"$fyk2oeqxpb7bd":8,"compound-J-27702-8":171,"verified-suppliers-J-27702-8":396},{"rates":4,"source":7},{"USD":5,"CNY":6},1,6.691314,"live",{"rows":9,"total":170,"current":5,"size":145},[10,33,45,60,74,85,96,113,123,135,146,158],{"slug":11,"cid":12,"imgSvg":13,"name":14,"nameZh":15,"cas":16,"formula":17,"iupac":14,"category":18,"categoryName":19,"categoryEnName":20,"industry":21,"tags":22,"offersCount":24,"supplierCount":25,"bestOffer":26},"843627791009189888","J-1971488-8","\u002Fimages\u002Fchem_structures_svg\u002F399\u002F65845-61-6.svg","N-Methylcyclohexanamine hydrochloride","N-甲基环己胺盐酸盐","65845-61-6","C7H16ClN","acids","有机酸","Organic Acids","",[23],"In Stock",4,2,{"unitPrice":27,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},2.64,"500g","CNY","China","CN","in-stock",{"slug":34,"cid":35,"imgSvg":36,"name":37,"nameZh":38,"cas":39,"formula":40,"iupac":37,"category":18,"categoryName":19,"categoryEnName":20,"industry":21,"tags":41,"offersCount":24,"supplierCount":5,"bestOffer":42},"785882541994283008","J-1323843-4","\u002Fimages\u002Fchem_structures_svg\u002F104\u002F67627-18-3.svg","Potassium indigotrisulfonate","靛蓝三磺酸钾","67627-18-3","C16H7K3N2O11S3",[23],{"unitPrice":43,"pack":44,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},180,"5g",{"slug":46,"cid":47,"imgSvg":48,"name":49,"nameZh":50,"cas":51,"formula":52,"iupac":49,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":56,"offersCount":57,"supplierCount":25,"bestOffer":58},"785889752443260928","J-28559-9","\u002Fimages\u002Fchem_structures_svg\u002F292\u002F15060-55-6.svg","Ammonium tetrathiomolybdate","四硫钼酸铵","15060-55-6","H8MoN2S4","inorganic","无机化合物","Inorganic Chemicals",[23],7,{"unitPrice":59,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},24,{"slug":61,"cid":62,"imgSvg":63,"name":64,"nameZh":65,"cas":66,"formula":67,"iupac":64,"category":18,"categoryName":19,"categoryEnName":20,"industry":21,"tags":68,"offersCount":69,"supplierCount":25,"bestOffer":70},"855452191530422272","J-1994428-7","\u002Fimages\u002Fchem_structures_svg\u002F500\u002F16350-96-2.svg","N-benzylcyclohexanamine.hydrochloride","N-苄基环己胺盐酸盐","16350-96-2","C13H20ClN",[23],5,{"unitPrice":71,"pack":72,"currency":29,"origin":73,"originFlag":31,"moq":21,"stock":32},6,"1000g","中国",{"slug":75,"cid":76,"imgSvg":77,"name":78,"nameZh":79,"cas":80,"formula":81,"iupac":78,"category":18,"categoryName":19,"categoryEnName":20,"industry":21,"tags":82,"offersCount":25,"supplierCount":25,"bestOffer":83},"785871840001134592","J-982001-0","\u002Fimages\u002Fchem_structures_svg\u002F001\u002F10517-44-9.svg","1,3-Diaminopropane dihydrochloride","1,3-二氨基丙烷二盐酸盐","10517-44-9","C3H12Cl2N2",[23],{"unitPrice":84,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},3.78,{"slug":86,"cid":87,"imgSvg":88,"name":89,"nameZh":90,"cas":91,"formula":92,"iupac":89,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":93,"offersCount":57,"supplierCount":94,"bestOffer":95},"785880365658017792","J-14975-6","\u002Fimages\u002Fchem_structures_svg\u002F262\u002F12003-67-7.svg","Lithium aluminate","氧化铝锂","12003-67-7","AlHLiO2",[23],3,{"unitPrice":94,"pack":28,"currency":29,"origin":73,"originFlag":31,"moq":21,"stock":32},{"slug":97,"cid":98,"imgSvg":99,"name":100,"nameZh":101,"cas":102,"formula":103,"iupac":100,"category":104,"categoryName":105,"categoryEnName":106,"industry":21,"tags":107,"offersCount":108,"supplierCount":108,"bestOffer":109},"785871830249377792","J-6931-9","\u002Fimages\u002Fchem_structures_svg\u002F456\u002F58068-80-7.svg","1-Octanoylbenzotriazole","N-辛酰苯并三唑","58068-80-7","C14H19N3O","aromatics","芳香烃","Aromatic Hydrocarbons",[],0,{"unitPrice":110,"pack":21,"currency":111,"origin":21,"originFlag":21,"moq":21,"stock":112},9007199254740991,"USD","made-to-order",{"slug":114,"cid":115,"imgSvg":116,"name":117,"nameZh":118,"cas":119,"formula":120,"iupac":117,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":121,"offersCount":69,"supplierCount":25,"bestOffer":122},"785871842446413824","J-1960944-3","\u002Fimages\u002Fchem_structures_svg\u002F495\u002F10534-86-8.svg","Hexaamminecobalt(III) nitrate","六氨合钴(III)硝酸盐","10534-86-8","CoH18N9O9",[23],{"unitPrice":71,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},{"slug":124,"cid":125,"imgSvg":126,"name":127,"nameZh":128,"cas":129,"formula":130,"iupac":127,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":131,"offersCount":24,"supplierCount":25,"bestOffer":132},"785871842576437248","J-814544-6","\u002Fimages\u002Fchem_structures_svg\u002F221\u002F12037-42-2.svg","vanadium oxide","氧化钒","12037-42-2","O13V6",[23],{"unitPrice":133,"pack":134,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},112.8,"100g",{"slug":136,"cid":137,"imgSvg":138,"name":139,"nameZh":140,"cas":141,"formula":142,"iupac":139,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":143,"offersCount":57,"supplierCount":5,"bestOffer":144},"785871842647740416","J-1333345-2","\u002Fimages\u002Fchem_structures_svg\u002F479\u002F26490-63-1.svg","COBALT TETRAFLUOROBORATE HEXAHYDRATE","四氟化硼钴水合物","26490-63-1","B2CoF8H12O6",[23],{"unitPrice":145,"pack":134,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},12,{"slug":147,"cid":148,"imgSvg":149,"name":150,"nameZh":151,"cas":152,"formula":153,"iupac":150,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":154,"offersCount":155,"supplierCount":94,"bestOffer":156},"785871842698072064","J-814953-0","\u002Fimages\u002Fchem_structures_svg\u002F432\u002F72259-10-0.svg","Copper(II) tetrafluoroborate hexahydrate","六水合四氟硼酸铜(II)","72259-10-0","B2CuF8H12O6",[23],10,{"unitPrice":157,"pack":28,"currency":29,"origin":21,"originFlag":21,"moq":21,"stock":32},2.6,{"slug":159,"cid":160,"imgSvg":161,"name":162,"nameZh":163,"cas":164,"formula":165,"iupac":162,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":166,"offersCount":25,"supplierCount":5,"bestOffer":168},"785871863254355968","J-1990080-7","\u002Fimages\u002Fchem_structures_svg\u002F149\u002F123333-60-8.svg","Cerium(IV) sulfate hydrate","铈(IV)硫酸盐水合物","123333-60-8","CeH2O9S2",[167],"Made to Order",{"unitPrice":169,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},5.6,3204,{"slug":172,"cid":173,"imgSvg":174,"name":175,"nameZh":175,"cas":176,"formula":177,"iupac":175,"mdl":21,"mw":178,"category":179,"categoryName":180,"categoryEnName":181,"industry":21,"tags":182,"synonyms":183,"properties":190,"ghs":245,"offers":250,"activity":251,"upstream":273,"downstream":298,"customs":300,"safetyRows":313,"toxicity":353,"msds":354,"updatedAt":355,"isProhibited":356,"related":357,"__ts":394,"__lang":395,"__slug":173},"785889446045159424","J-27702-8","\u002Fimages\u002Fchem_structures_svg\u002F053\u002F36791-04-5.svg","利巴韦林","36791-04-5","C8H12N4O5","244.205","organic","有机化合物","Organic Compounds",[],[184,185,186,187,188,189],"病毒唑","三氮唑核苷","三唑核苷","1-β-D-呋喃核糖基-1H-1,2,4-三氮唑-3-羧酰胺","1-β-D-呋喃核糖-1,2,4-三氮唑-3-羟酰胺","尼斯可",[191,195,199,203,207,211,214,217,220,224,228,232,235,238,242],{"label":192,"labelZh":192,"value":193,"prop":194},"Melting Point","174-176°C","meltingPoint",{"label":196,"labelZh":196,"value":197,"prop":198},"Boiling Point","639.8±65.0 °C at 760 mmHg","boilingPoint",{"label":200,"labelZh":200,"value":201,"prop":202},"Density","2.1±0.1 g\u002Fcm3","density",{"label":204,"labelZh":204,"value":205,"prop":206},"Flash Point","340.7±34.3 °C","flashPoint",{"label":208,"labelZh":209,"value":210},"Exact Mass","精确质量","244.080765",{"label":212,"labelZh":212,"value":213},"PSA","143.72000",{"label":215,"labelZh":215,"value":216},"LogP","-2.26",{"label":218,"labelZh":218,"value":219},"外观性状","无色固体",{"label":221,"labelZh":222,"value":223},"Vapor Pressure","蒸汽压","0.0±2.0 mmHg at 25°C",{"label":225,"labelZh":226,"value":227},"Refractive Index","折射率","1.823",{"label":229,"labelZh":230,"value":231},"Storage Conditions","储存条件","避光，密闭保存",{"label":233,"labelZh":233,"value":234},"稳定性","本品在体内转变为三唑核苷酸，抑制次黄嘌呤核苷酸脱氢酶，阻断鸟苷酸的生物合成，从而抑制DAN的合成，具有广谱抗病毒 （DNA病毒、RNA病毒）和抗肿瘤的作用。",{"label":236,"labelZh":236,"value":237},"水溶解性",">=10 G\u002F100 ML AT 19 ºC",{"label":239,"labelZh":240,"value":241},"Computational Chemistry","计算化学","1、 疏水参数计算参考值（XlogP）：-1.8\n2、 氢键供体数量：4\n3、 氢键受体数量：7\n4、 可旋转化学键数量：3\n5、 拓扑分子极性表面积（TPSA）：144\n6、 重原子数量：17\n7、 表面电荷：0\n8、 复杂度：304\n9、 同位素原子数量：0\n10、 确定原子立构中心数量：4\n11、 不确定原子立构中心数量：0\n12、 确定化学键立构中心数量：0\n13、 不确定化学键立构中心数量：0\n14、 共价键单元数量：1",{"label":243,"labelZh":243,"value":244},"更多","1.性状：白色结晶粉末。\n2.熔点℃：174-176\n3.溶解性：易溶于水，微溶于乙醇、氯仿和醚等。",{"pictogram":246,"signal":247,"hazards":248},"Health Hazard","Danger",[249],"H360 — May damage fertility or the unborn child \u002F 可能对生育能力或胎儿造成伤害",[],[252,255,258,261,264,267,270],{"key":253,"value":254},"描述","Ribavirin是广谱的抗病毒药,可抑制HCV,HIVl,RSV等病毒。",{"key":256,"value":257},"相关类别","信号通路\n>>\n抗感染\n>>\nHCV\n信号通路\n>>\n抗感染\n>>\nRSV\n研究领域\n>>\n感染",{"key":259,"value":260},"体外研究","利巴韦林(5,10和20μM)对未刺激的小胶质细胞中的细胞活力和亚硝酸盐水平均不产生任何显着影响。用5,10和20μM利巴韦林处理LPS刺激的小胶质细胞分别诱导NO 2水平降低43％(p \u003C0.05),53％(p \u003C0.05)和59％(p \u003C0.05)。利巴韦林(10 mM)在未刺激的培养物中显着降低细胞表面积,但在LPS刺激的小胶质细胞中显着降低细胞表面积(32％,p \u003C0.05)[3]。利巴韦林对DENV具有活性,在A549细胞中EC50为3μM,并且CM-10-18与利巴韦林的组合在病毒复制的减少中表现出明显的增强[4]。",{"key":262,"value":263},"体内研究","给予JAT联合干扰素和利巴韦林可显着降低ALT,AST活性和胆红素水平(p \u003C0.01)。单独的JAT,干扰素或利巴韦林与CCl4,肝脏似乎表现出一些针对CCl4的肝脏保护作用,正如肝线的存在,没有坏死和较少的脂肪浸润所证明的。分别或组合用JAT,Peg-干扰素和利巴韦林处理的组显示TGF-β和Bax的表达降低。在通过干扰素,利巴韦林和JAT的三重组合治疗的组中,p53的表达水平显着降低[1]。利巴韦林胶囊(400mg利巴韦林)处理的Wistar大鼠显示活化素A显着降低,并且血清和肝脏水平的卵泡抑素显着增加。只有当利巴韦林与IFN-α或Peg-IFN-α联合使用时,利巴韦林才具有很强的抗病毒活性[2]。利巴韦林(40mg\u002Fkg,口服)显着改善CM-10-18在小鼠中的抗病毒功效。利巴韦林抑制培养细胞中的DENV病毒感染,但它在减少单药治疗中的病毒血症方面无效[4]。",{"key":265,"value":266},"细胞实验","利巴韦林对小胶质细胞活力的影响通过磺酰罗丹明B（SRB）化学敏感性测定来评估。简而言之，在存在或不存在利巴韦林的情况下，将LPS刺激的小神经胶质细胞温育48小时。然后，将细胞在10％（w \u002F v）三氯乙酸中于4℃固定1小时，在自来水中漂洗并用1％乙酸（100μL\u002F孔）中的0.4％（w \u002F v）SRB染色。在室温（RT）下保持30分钟。然后将细胞在1％乙酸中漂洗三次以除去未结合的染色剂。每孔用200μL10mMTris碱（pH 10.5）提取蛋白质结合的染色剂。在540nm处读取光密度，在670nm处进行校正。结果表示为对照（未刺激\u002F未处理的小神经胶质细胞）的百分比，其任意设定为100％。",{"key":268,"value":269},"动物实验","使用AG129小鼠中的登革热病毒血症模型（I型和II型干扰素受体缺陷）主要进行体内功效实验。每个实验每个给药组包含6只小鼠（7至8周龄）。通过ip注射以5×10 6 pfu \u002F小鼠用DENV（血清型2，TSV01株）攻击小鼠。每隔12小时给予Imino糖两次，并且每天一次给予利巴韦林，感染后连续3天。在感染后3天抽取血样用于通过噬斑测定法测定血浆病毒滴度。",{"key":271,"value":272},"参考文献","[1].\nAbdel-Hamid NM, et al. Synergistic Effects of Jerusalem Artichoke in Combination with Pegylated Interferon Alfa-2a and Ribavirin Against Hepatic Fibrosis in Rats. Asian Pac J Cancer Prev. 2016;17(4):1979-85.\n[2].\nRefaat B, et al. The effects of pegylated interferon-α and ribavirin on liver and serum concentrations of activin-A and follistatin in normal Wistar rat: a preliminary report. BMC Res Notes. 2015 Jun 26;8:265\n[3].\nSavic D, et al. Ribavirin shows immunomodulatory effects on activated microglia. Immunopharmacol Immunotoxicol. 2014 Dec;36(6):433-41\n[4].\nChang J, et al. Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo. Antiviral Res. 2011 Jan;89(1):26-34",[274,280,286,292],{"slug":275,"cid":276,"name":277,"nameZh":277,"cas":278,"imgSvg":279},"785897229163434000","J-1605924-7","1-Β-D-呋喃核糖基-1H-...","38934-69-9","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F015\u002F38934-69-9.svg",{"slug":281,"cid":282,"name":283,"nameZh":283,"cas":284,"imgSvg":285},"785892168530137100","J-32126-4","2H-1,2,4-三氮唑-3-甲酰胺","3641-08-5","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F413\u002F3641-08-5.svg",{"slug":287,"cid":288,"name":289,"nameZh":289,"cas":290,"imgSvg":291},"785888633780441100","J-1108846-8","鸟苷","118-00-3","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F347\u002F118-00-3.svg",{"slug":293,"cid":294,"name":295,"nameZh":295,"cas":296,"imgSvg":297},"785888406944092200","J-1110166-6","尿苷","58-96-8","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F170\u002F58-96-8.svg",[299],{"slug":281,"cid":282,"name":283,"nameZh":283,"cas":284,"imgSvg":285},[301,304,307,310],{"key":302,"value":303},"海关编码","2933290090",{"key":305,"value":306},"中文概述","2933290090. 其他结构含非稠合咪唑环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%",{"key":308,"value":309},"申报要素","品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期",{"key":311,"value":312},"Summary","2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%",[314,317,319,322,325,328,331,334,337,340,343,346,349,352],{"key":315,"value":316},"符号","GHS08",{"key":318,"value":247},"信号词",{"key":320,"value":321},"危害声明","H360",{"key":323,"value":324},"警示性声明","P201-P280-P308 + P313",{"key":326,"value":327},"个人防护装备","Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges",{"key":329,"value":330},"危害码 (欧洲)","Xi",{"key":332,"value":333},"风险声明 (欧洲)","R61",{"key":335,"value":336},"安全声明 (欧洲)","53-22-45-37\u002F39-26",{"key":338,"value":339},"危险品运输编码","UN 3152 9\u002FPG 2",{"key":341,"value":342},"WGK德国","3",{"key":344,"value":345},"RTECS号","XZ4250000",{"key":347,"value":348},"包装等级","II",{"key":350,"value":351},"危险类别","9",{"key":302,"value":303},"\u003Ctd>\n\n\u003Cp>\u003Ca href=\"\u002Fen\u002Fcas\u002F36791-04-5_670582.html#duXinDiv\">利巴韦林毒性英文版\u003C\u002Fa>\u003C\u002Fp>\n\n\u003C\u002Ftd>","\u003Ctd>\n\n\u003Cb>1.1 产品标识符\u003C\u002Fb>\n\u003Cbr \u002F> : Ribavirin\n\u003Cbr \u002F> 产品名称\n\u003Cbr \u002F>\n\u003Cb>1.2 鉴别的其他方法\u003C\u002Fb>\n\u003Cbr \u002F> 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide\n\u003Cbr \u002F>\n\u003Cb>1.3 有关的确定了的物质或混合物的用途和建议不适合的用途\u003C\u002Fb>\n\u003Cbr \u002F> 仅供科研用途，不作为药物、家庭备用药或其它用途。\n\u003Cbr \u002F>\n\n\u003Cstrong>模块2. 危险性概述\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>2.1 GHS分类\u003C\u002Fb>\n\u003Cbr \u002F> 急性毒性, 经口 (类别5)\n\u003Cbr \u002F> 致畸性 (类别1B)\n\u003Cbr \u002F>\n\u003Cb>2.2 GHS 标记要素，包括预防性的陈述\u003C\u002Fb>\n\u003Cbr \u002F> 象形图\n\u003Cbr \u002F> 警示词危险\n\u003Cbr \u002F> 危险申明\n\u003Cbr \u002F> H303吞咽可能有害。\n\u003Cbr \u002F> H360可能对生育能力或胎儿造成伤害。\n\u003Cbr \u002F> 警告申明\n\u003Cbr \u002F> 预防\n\u003Cbr \u002F> P201在使用前获取特别指示。\n\u003Cbr \u002F> P202在读懂所有安全防范措施之前切勿操作。\n\u003Cbr \u002F> P281使用所需的个人防护设备。\n\u003Cbr \u002F> 措施\n\u003Cbr \u002F> P308 + P313如接触到或有疑虑：求医\u002F 就诊。\n\u003Cbr \u002F> 储存\n\u003Cbr \u002F> P405存放处须加锁。\n\u003Cbr \u002F> 处理\n\u003Cbr \u002F> P501将内容物\u002F 容器处理到得到批准的废物处理厂。\n\u003Cbr \u002F> 只限于专业使用者。\n\u003Cbr \u002F>\n\u003Cb>2.3 其它危害物 - 无\u003C\u002Fb>\n\u003Cbr \u002F>\n\n\u003Cstrong>模块3. 成分\u002F组成信息\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>3.1 物 质\u003C\u002Fb>\n\u003Cbr \u002F> : 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide\n\u003Cbr \u002F> 别名\n\u003Cbr \u002F> : C8H12N4O5\n\u003Cbr \u002F> 分子式\n\u003Cbr \u002F> : 244.20 g\u002Fmol\n\u003Cbr \u002F> 分子量\n\u003Cbr \u002F> 组分浓度或浓度范围\n\u003Cbr \u002F> Ribavirin\n\u003Cbr \u002F> -\n\u003Cbr \u002F> CAS 号36791-04-5\n\u003Cbr \u002F>\n\n\u003Cstrong>模块4. 急救措施\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>4.1 必要的急救措施描述\u003C\u002Fb>\n\u003Cbr \u002F> 一般的建议\n\u003Cbr \u002F> 请教医生。 出示此安全技术说明书给到现场的医生看。\n\u003Cbr \u002F> 吸入\n\u003Cbr \u002F> 如果吸入,请将患者移到新鲜空气处。 如果停止了呼吸,给于人工呼吸。 请教医生。\n\u003Cbr \u002F> 皮肤接触\n\u003Cbr \u002F> 用肥皂和大量的水冲洗。 请教医生。\n\u003Cbr \u002F> 眼睛接触\n\u003Cbr \u002F> 用水冲洗眼睛作为预防措施。\n\u003Cbr \u002F> 食入\n\u003Cbr \u002F> 切勿给失去知觉者从嘴里喂食任何东西。 用水漱口。 请教医生。\n\u003Cbr \u002F>\n\u003Cb>4.2 主要症状和影响，急性和迟发效应\u003C\u002Fb>\n\u003Cbr \u002F> 据我们所知，此化学，物理和毒性性质尚未经完整的研究。, 头痛, 疲劳, 贫血, 呼吸失调, 皮疹\n\u003Cbr \u002F>\n\u003Cb>4.3 及时的医疗处理和所需的特殊处理的说明和指示\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块5. 消防措施\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>5.1 灭火介质\u003C\u002Fb>\n\u003Cbr \u002F> 灭火方法及灭火剂\n\u003Cbr \u002F> 用水雾,耐醇泡沫,干粉或二氧化碳灭火。\n\u003Cbr \u002F>\n\u003Cb>5.2 源于此物质或混合物的特别的危害\u003C\u002Fb>\n\u003Cbr \u002F> 碳氧化物, 氮氧化物\n\u003Cbr \u002F>\n\u003Cb>5.3 给消防员的建议\u003C\u002Fb>\n\u003Cbr \u002F> 如必要的话,戴自给式呼吸器去救火。\n\u003Cbr \u002F>\n\u003Cb>5.4 进一步信息\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块6. 泄露应急处理\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>6.1 人员的预防,防护设备和紧急处理程序\u003C\u002Fb>\n\u003Cbr \u002F> 使用个人防护设备。 防止粉尘的生成。 防止吸入蒸汽、气雾或气体。 保证充分的通风。\n\u003Cbr \u002F> 将人员撤离到安全区域。 避免吸入粉尘。\n\u003Cbr \u002F>\n\u003Cb>6.2 环境保护措施\u003C\u002Fb>\n\u003Cbr \u002F> 在确保安全的前提下，采取措施防止进一步的泄漏或溢出。 不要让产物进入下水道。\n\u003Cbr \u002F>\n\u003Cb>6.3 抑制和清除溢出物的方法和材料\u003C\u002Fb>\n\u003Cbr \u002F> 收集、处理泄漏物，不要产生灰尘。 扫掉和铲掉。 存放进适当的闭口容器中待处理。\n\u003Cbr \u002F>\n\u003Cb>6.4 参考其他部分\u003C\u002Fb>\n\u003Cbr \u002F> 丢弃处理请参阅第13节。\n\u003Cbr \u002F>\n\n\u003Cstrong>模块7. 操作处置与储存\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>7.1 安全操作的注意事项\u003C\u002Fb>\n\u003Cbr \u002F> 防止粉尘和气溶胶生成。避免曝露：使用前需要获得专门的指导。\n\u003Cbr \u002F> 在有粉尘生成的地方,提供合适的排风设备。一般性的防火保护措施。\n\u003Cbr \u002F>\n\u003Cb>7.2 安全储存的条件,包括任何不兼容性\u003C\u002Fb>\n\u003Cbr \u002F> 贮存在阴凉处。 容器保持紧闭，储存在干燥通风处。\n\u003Cbr \u002F> 建议的贮存温度： 2 - 8 °C\n\u003Cbr \u002F>\n\u003Cb>7.3 特定用途\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块8. 接触控制和个体防护\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>8.1 容许浓度\u003C\u002Fb>\n\u003Cbr \u002F> 最高容许浓度\n\u003Cbr \u002F> 没有已知的国家规定的暴露极限。\n\u003Cbr \u002F>\n\u003Cb>8.2 暴露控制\u003C\u002Fb>\n\u003Cbr \u002F> 适当的技术控制\n\u003Cbr \u002F> 按照良好工业和安全规范操作。 休息前和工作结束时洗手。\n\u003Cbr \u002F> 个体防护设备\n\u003Cbr \u002F> 眼\u002F面保护\n\u003Cbr \u002F> 带有防护边罩的安全眼镜符合 EN166要求请使用经官方标准如NIOSH (美国) 或 EN 166(欧盟)\n\u003Cbr \u002F> 检测与批准的设备防护眼部。\n\u003Cbr \u002F> 皮肤保护\n\u003Cbr \u002F> 戴手套取 手套在使用前必须受检查。\n\u003Cbr \u002F> 请使用合适的方法脱除手套(不要接触手套外部表面),避免任何皮肤部位接触此产品.\n\u003Cbr \u002F> 使用后请将被污染过的手套根据相关法律法规和有效的实验室规章程序谨慎处理. 请清洗并吹干双手\n\u003Cbr \u002F> 所选择的保护手套必须符合EU的89\u002F686\u002FEEC规定和从它衍生出来的EN 376标准。\n\u003Cbr \u002F> 身体保护\n\u003Cbr \u002F> 防渗透的衣服, 防护设备的类型必须根据特定工作场所中的危险物的浓度和含量来选择。\n\u003Cbr \u002F> 呼吸系统防护\n\u003Cbr \u002F> 如危险性评测显示需要使用空气净化的防毒面具，请使用全面罩式多功能微粒防毒面具N100型（US\n\u003Cbr \u002F> ）或P3型（EN\n\u003Cbr \u002F> 143）防毒面具筒作为工程控制的候补。如果防毒面具是保护的唯一方式，则使用全面罩式送风防毒\n\u003Cbr \u002F> 面具。 呼吸器使用经过测试并通过政府标准如NIOSH（US）或CEN（EU）的呼吸器和零件。\n\u003Cbr \u002F>\n\n\u003Cstrong>模块9. 理化特性\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>9.1 基本的理化特性的信息\u003C\u002Fb>\n\u003Cbr \u002F> a) 外观与性状\n\u003Cbr \u002F> 形状: 固体\n\u003Cbr \u002F> b) 气味\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> c) 气味阈值\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> d) pH值\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> e) 熔点\u002F凝固点\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> f) 起始沸点和沸程\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> g) 闪点\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> h) 蒸发速率\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> i) 易燃性(固体,气体)\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> j) 高的\u002F低的燃烧性或爆炸性限度 无数据资料\n\u003Cbr \u002F> k) 蒸汽压\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> l) 蒸汽密度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> m) 相对密度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> n) 水溶性\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> o) n-辛醇\u002F水分配系数\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> p) 自燃温度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> q) 分解温度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> r) 粘度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块10. 稳定性和反应活性\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>10.1 反应性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>10.2 稳定性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>10.3 危险反应的可能性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>10.4 应避免的条件\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>10.5 不兼容的材料\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>10.6 危险的分解产物\u003C\u002Fb>\n\u003Cbr \u002F> 其它分解产物 - 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块11. 毒理学资料\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>11.1 毒理学影响的信息\u003C\u002Fb>\n\u003Cbr \u002F> 急性毒性\n\u003Cbr \u002F> 半数致死剂量 (LD50) 经口 - 大鼠 - 2,700 mg\u002Fkg\n\u003Cbr \u002F> 皮肤刺激或腐蚀\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 眼睛刺激或腐蚀\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 呼吸道或皮肤过敏\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 生殖细胞突变性\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 致癌性\n\u003Cbr \u002F> IARC:\n\u003Cbr \u002F> 此产品中没有大于或等于 0。1%含量的组分被 IARC鉴别为可能的或肯定的人类致癌物。\n\u003Cbr \u002F> 生殖毒性\n\u003Cbr \u002F> 假设有人类生殖毒性\n\u003Cbr \u002F> 特异性靶器官系统毒性（一次接触）\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 特异性靶器官系统毒性（反复接触）\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 吸入危险\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 潜在的健康影响\n\u003Cbr \u002F> 吸入吸入可能有害。 可能引起呼吸道刺激。\n\u003Cbr \u002F> 摄入如服入是有害的。\n\u003Cbr \u002F> 皮肤如果通过皮肤吸收可能是有害的。 可能引起皮肤刺激。\n\u003Cbr \u002F> 眼睛可能引起眼睛刺激。\n\u003Cbr \u002F> 接触后的征兆和症状\n\u003Cbr \u002F> 据我们所知，此化学，物理和毒性性质尚未经完整的研究。, 头痛, 疲劳, 贫血, 呼吸失调, 皮疹\n\u003Cbr \u002F> 附加说明\n\u003Cbr \u002F> 化学物质毒性作用登记: XZ4250000\n\u003Cbr \u002F>\n\n\u003Cstrong>模块12. 生态学资料\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>12.1 生态毒性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.2 持久存留性和降解性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.3 潜在的生物蓄积性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.4 土壤中的迁移性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.5 PBT 和 vPvB的结果评价\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.6 其它不利的影响\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块13. 废弃处置\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>13.1 废物处理方法\u003C\u002Fb>\n\u003Cbr \u002F> 产品\n\u003Cbr \u002F> 将剩余的和未回收的溶液交给处理公司。 联系专业的拥有废弃物处理执照的机构来处理此物质。\n\u003Cbr \u002F> 与易燃溶剂相溶或者相混合，在备有燃烧后处理和洗刷作用的化学焚化炉中燃烧\n\u003Cbr \u002F> 受污染的容器和包装\n\u003Cbr \u002F> 作为未用过的产品弃置。\n\u003Cbr \u002F>\n\n\u003Cstrong>模块14. 运输信息\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>14.1 联合国危险货物编号\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: -国际海运危规: -国际空运危规: -\n\u003Cbr \u002F>\n\u003Cb>14.2 联合国（UN）规定的名称\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: 非危险货物\n\u003Cbr \u002F> 国际海运危规: 非危险货物\n\u003Cbr \u002F> 国际空运危规: 非危险货物\n\u003Cbr \u002F>\n\u003Cb>14.3 运输危险类别\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: -国际海运危规: -国际空运危规: -\n\u003Cbr \u002F>\n\u003Cb>14.4 包裹组\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: -国际海运危规: -国际空运危规: -\n\u003Cbr \u002F>\n\u003Cb>14.5 环境危险\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: 否国际海运危规 海运污染物: 否国际空运危规: 否\n\u003Cbr \u002F>\n\u003Cb>14.6 对使用者的特别提醒\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cbr \u002F>\n\n\u003Cstrong> 模块 15 - 法规信息 \u003C\u002Fstrong>\n\u003Cbr \u002F>N\u002FA\n\u003Cbr \u002F>\n\u003Cbr \u002F>\n\n\u003Cstrong> 模块16 - 其他信息 \u003C\u002Fstrong>\n\u003Cbr \u002F>N\u002FA\n\u003Cbr \u002F>\u003Cbr \u002F>\u003Cbr \u002F>\u003Cbr \u002F>\u003Cbr \u002F>\u003Cbr \u002F>\u003Cbr \u002F>\u003Cbr \u002F>\u003Cbr \u002F>\u003Cbr \u002F>\u003Cbr \u002F>\n\n\u003C\u002Ftd>","2026-08-21T07:51:12.859463Z",false,[358,364,370,376,382,388],{"slug":359,"cid":360,"name":361,"nameZh":362,"cas":363},"785880378626805760","J-1974556-7","Pidotimod","匹多莫德","121808-62-6",{"slug":365,"cid":366,"name":367,"nameZh":368,"cas":369},"785883686766645248","J-8750-0","D-Biotin","D-生物素","58-85-5",{"slug":371,"cid":372,"name":373,"nameZh":374,"cas":375},"785875461283516416","J-1030078-9","1,1,7,7-Tetramethyl-1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinolin-8-ol","1,1,7,7-四甲基-8-羟基久洛尼定","115704-83-1",{"slug":377,"cid":378,"name":379,"nameZh":380,"cas":381},"785876833009668096","J-14831-7","Aluminum n-butoxide","正-丁氧基铝","3085-30-1",{"slug":383,"cid":384,"name":385,"nameZh":386,"cas":387},"785884196030648320","J-23062-3","Amobam","代森铵","3566-10-7",{"slug":389,"cid":390,"name":391,"nameZh":392,"cas":393},"785897851497484288","J-1029313-9","Lead cyanamide","氨基氰铅(2+)盐(1:1)","20837-86-9",1792618582716,"zh-CN",[]]